Biome Australia Ltd · ASX:BIO
Biome Australia — Investor Presentation (April 2024)
40 slides from Biome Australia's investor presentation, Apr 11, 2024
Slide 1: Company Presentation
Biome Australia Limited | April 2024 Company Presentation Blair Norfolk, CEO & Managing Director
Slide 2: Disclaimer
Biome Australia Commercial in confidence Disclaimer This presentation and the information contained within it (the Past performance information included in this presentation is The recipient must, and agrees with the Company that it will, “information”) has been prepared solely for the use and benefit
Slide 3: Our mission
Biome Australia Commercial in confidence Our mission To prevent disease, improve health outcomes and quality of life, and make our products accessible to all Company Presentation | August April 2024 2023 3
Slide 4: About Biome Australia
Biome Australia Commercial in confidence About Biome Australia Biome Australia (ASX: BIO) is focused on becoming a global leader in the complementary medicine industry, offering clinically-proven condition-specific probiotic products fueled by novel clinical research programs to cement and extend the e
Slide 5: Biome Australia Company Presentation | April 2024 Commercial in confidence
Biome Australia Commercial in confidence Company Presentation | April 2024 5
Slide 6: 01. Investment and Business Highlights
Biome Australia Commercial in confidence 01. Investment and Business Highlights Company Presentation | August April 2024 2023 6
Slide 7: Biome Business Opportunity
Biome Australia Commercial in confidence Biome Business Novel range of Live Biotherapeutics with co-prescribing medication opportunity Opportunity Landmark IP Deal executed on novel probiotic strains Three ongoing clinical trials on key products, see slide 21 International Expansion — UK, Irish healt
Slide 8: Biome Business Opportunity
Biome Australia Commercial in confidence Biome Business Over 5,000 distribution points (Aus) following successful launch with Priceline Pharmacy Opportunity Average shopper — 2.1 units per transaction and 6 visits per year in pharmacy (TerryWhite) #1 Professional Probiotic brand in Australian Healthc
Slide 9: Financial Highlights
Biome Australia Commercial in confidence Financial Highlights Financial performance FYTD24 (Mar24) sales $9.2m ‒ up 76.5% (vs pcp) Quarterly sales of $3.2m in March 2024 Sales Forecast upgraded to $12.5m (Jan 24) Q3 FY24 same stores sales up 61.4% vs PCP Positive underlying cash flow and EBITDA in Q3
Slide 10: Quarterly Operating Cash Flow
Biome Australia Commercial in confidence Quarterly Operating Cash Flow Company Presentation | April 2024 10
Slide 11: Growth Strategy
Biome Australia Commercial in confidence ‒ Increase Distribution in Pharmacy banner groups, HCPs and Medical Specialists ‒ Improve average sell through, same store sales and Increase product range. Grow Revenue ‒ Sales revenue increased: $832k (FY21) to $12.5m (F); equivalent to 4-Year CAGR of 97% ‒
Slide 12: Half-Yearly Key Financial data points
Biome Australia Commercial in confidence Half-Yearly— Key Financial data points Revenue Gross Profit NPAT (excl Share based payments & LTI) Company Presentation | April 2024 12
Slide 13: Annual Sales Revenue
Biome Australia Commercial in confidence Annual Sales Revenue Company Presentation | April 2024 13
Slide 14: 02. Activated Probiotics Range
Biome Australia Commercial in confidence 02. Activated Probiotics Range Company Presentation | August April 2024 2023 14
Slide 15: Activated Probiotics
Biome Australia Commercial in confidence Activated Probiotics Practitioners & Pharmacies CONSUMER BENEFITS 5x more effective delivery — MicrobacTM technology Shelf-stable Clinically documented probiotic strains Company Presentation | April 2024 15
Slide 16: 04. Distribution Network and Sales Model
Biome Australia Commercial in confidence 04. Distribution Network and Sales Model Company Presentation | August April 2024 2023 16
Slide 17: Australian Distribution Network
Biome Australia Commercial in confidence Australian Distribution Network Biome Australia currently has over 5000 distribution 5000+ Distribution points, between community pharmacies and Points independent health practitioners TerryWhite Chemmart—Activated Probiotics #1 growth brand in professional vi
Slide 18: Pharmacy Core Ranges Authorised Distribution Partners
Biome Australia Commercial in confidence Pharmacy Core Ranges Authorised Distribution Partners Company Presentation | April 2024 18
Slide 19: Training and Education Driven Sales Model
Biome Australia Commercial in confidence Training and Education Driven Sales Model Unique Education and Service Model Drives Sales in Australia, UK and NZ Education and Service Support • The Biome sales team is a mix of health qualified practitioner education consultants and territory managers • Prac
Slide 20: 03. Clinical Research
Biome Australia Commercial in confidence 03. Clinical Research Company Presentation | August April 2024 2023 20
Slide 21: Clinical pipeline — Indication overview
Biome Australia Commercial in confidence Clinical pipeline— ● Three ongoing clinical trials and further research Indication overview opportunities in discussion BIOME LIFT BIOME KIDS BIOME OSTEO Assessing the efficacy of the Biome Lift™ Analysing the influence of probiotic use on Examining the effect of
Slide 22: Biome Eczema Probiotic - Patient Results
Biome Australia Commercial in confidence Biome Eczema Probiotic - Patient Results “Jude and his mum has said thank you so much. They had tried every skin cream/soap/tablet and nothing has worked up until now. If you recall, Jude told one of the boys at school who asked what was wrong with his skin th
Slide 23: Biome Eczema Probiotic - Patient Results
Biome Australia Commercial in confidence Biome Eczema Probiotic - Patient Results Company Presentation | April 2024 23
Slide 24: Eczema - Patient Results
Biome Australia Commercial in confidence Biome Eczema - Patient Results Company Presentation | April 2024 24
Slide 25: Acne - Patient Results
Biome Australia Commercial in confidence Biome Acne - Patient Results I've been using the Biome Acne probiotic on my 12 year old for the mix of acne and peri-oral dermatitis he had going on. We saw great results in the first month and the bottom photo is after 2 months treatment. Company Presentation
Slide 26: 05. International Markets
Biome Australia Commercial in confidence 05. International Markets Company Presentation | August April 2024 2023 26
Slide 27: United Kingdom & EU New Growth Markets
Biome Australia Commercial in confidence United Kingdom & EU New Growth Markets Initial launch phase completed, UK team generating ~$500k in annualised sales through practitioner market PRACTITIONER (UK/EU) ● Add additional distributors in existing markets ● Add additional European distributors in ne
Slide 28: 06. New Product Development
Biome Australia Commercial in confidence 06. New Product Development Company Presentation | August April 2024 2023 28
Slide 29: Dental Probiotic
Biome Australia Commercial in confidence Biome Dental™ Probiotic To help support dental health and a healthy oral microbiome Clinically trialled formulation supported by 10 human trials Guaranteed potency The global periodontal disease treatment market was valued at USD 7.6 billion in 2021 and is exp
Slide 30: Key Product Research
Biome Australia Commercial in confidence Key Product Research The probiotic formulation in Biome Dental™ was compared to placebo and chlorhexidine mouthwash (standard treatment) in 60 healthy children. A significant decrease of plaque score and gingival index was seen on day 3 compared to placebo, and
Slide 31: Recovery Probiotic
Biome Australia Commercial in confidence Biome Recovery™ Probiotic To help reduce muscle inflammation and recovery time following exercise Clinically-trialled formulation Microbac™ technology: 5x more effective delivery Guaranteed potency The AU sports supplement category was worth AUD 1.4 billion in 2
Slide 32: Key Product Research
Biome Australia Commercial in confidence Key Product Research A double-blind, randomised, placebo-controlled trial investigated the effect of the probiotic formulation in Biome Recovery™ Probiotic on physical performance and levels of inflammation following muscle-damaging exercise in healthy men. Afte
Slide 33: Lax Probiotic
Biome Australia Commercial in confidence Biome Lax™ Probiotic To help promote bowel regularity and reduce bloating Clinically-trialled formulation Microbac™ technology: 5x more effective delivery Guaranteed potency The global constipation treatment market size was valued at USD 17.04 billion in 2020 a
Slide 34: Key Product Research
Biome Australia Commercial in confidence Key Product Research In a double-blind, randomised, placebo-controlled study across 5 years in over 300 subjects, the product formulation in Biome Lax™ was found to significantly improve the frequency of bowel movements, consistency of stool, ease of evacuation
Slide 35: 07. Marketing
Biome Australia Commercial in confidence 07. Marketing Company Presentation | August April 2024 2023 35
Slide 36: Public Health Campaign
Biome Australia Commercial in confidence Public Health Campaign Final reach: 2.5 million Australians Results by platform TVC: 950,000 Transport panels: 495,000 Street posters: 405,000 Meta campaigns: ~375,000 YouTube campaign: 247,000 Landing page quiz: 500+ submissions, 63% completion rate Company P
Slide 37: Pharmacy Advertising
Biome Australia Commercial in confidence Pharmacy Advertising Did you know a targeted Email banner probiotic can increase iron absorption? That’s right — there Print is a probiotic to improve iron absorption, providing a gentle approach to iron support… EDM Radio ad ft. Biome Iron Brand page Social c
Slide 38: Summary
Biome Australia Commercial in confidence Summary ● FYTD24 (Mar24) sales of $9.22m ‒ up 76.5% (vs pcp) ● Three ongoing clinical trials on key products, see slide 21 ● FY24 revenue target of $12.5m (73.6% met) ● Average shopper - 2.1 units per transaction ● Inventory balance of $2m (cost) at March 2024
Slide 39: Corporate Summary
Biome Australia Commercial in confidence Corporate Directors: 1) Mr Ilario Faenza (Chairman) Summary 2) 3) Ms Dominique Fisher AM Blair Vega Norfolk (Managing Director) ASX Code: BIO Current Assets (31 Mar 24) Listed Date: 30 November 2021 Cash at Bank $2,096,127 Accounts Receivables $2,439,950 Amoun
Slide 40: Contact details
Biome Australia Commercial in confidence Contact details: Blair Norfolk, CEO Douglas Loh, CFO e: corporate@biomeaustralia.com Websites: biomeaustralia.com activatedprobiotics.com.au Company Presentation | August 2023